HomeTDACU • NASDAQ
add
Translational Development Acquisition Corp
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 61.28K | 12,156.60% |
Net income | -61.28K | -12,156.60% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 224.04K | — |
Total assets | 393.77K | — |
Total liabilities | 964.40K | — |
Total equity | -570.63K | — |
Shares outstanding | 4.05M | — |
Price to book | -71.70 | — |
Return on assets | -65.64% | — |
Return on capital | -2,041.14% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -61.28K | -12,156.60% |
Cash from operations | -40.48K | — |
Cash from investing | — | — |
Cash from financing | 192.50K | — |
Net change in cash | 152.02K | — |
Free cash flow | 122.23K | — |
About
Founded
2022
